Produkty 566-27-8

CAS 566-27-8 występuje w naszej ofercie pod nazwami: 7-beta-Hydroxy-Cholesterol, 7Beta-Hydroxy Cholesterol, >95% (HPLC), 7 Beta-Hydroxycholesterol, 7β–hydroxy Cholesterol, 7b-Hydroxy cholesterol. Oferty producentów: Chemat Brand, TRC, TargetMol, GLPBio, Biosynth. Dostępne opakowania: on request, 10mg, 1mg, 5mg, 2mg, 100mg, 25MG, Get quote.

7-beta-Hydroxy-Cholesterol
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
7Beta-Hydroxy Cholesterol, >95% (HPLC)
TRC
  • opakowanie: 10mg, 1mg, 5mg
  • Warianty: 3
Zobacz produkt
7 Beta-Hydroxycholesterol
TargetMol, Sigma-Aldrich
  • opakowanie: 1mg, 5mg, 10mg, 25MG
  • Warianty: 6
od 545,46
Zobacz produkt
7β–hydroxy Cholesterol
GLPBio
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 615,76
Zobacz produkt
7b-Hydroxy cholesterol
Biosynth
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 4
Zobacz produkt
7-beta-Hydroxycholesterol, 95.00%
Chemat
  • opakowanie: 100mg, 10mg, 5mg
  • Warianty: 3
od 1364,51
Zobacz produkt
(3S,7R,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol
Chemat
  • opakowanie: 25mg, 1mg, 5mg
  • Warianty: 3
od 352,40
Zobacz produkt
7β-Hydroxycholesterol (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
7β-Hydroxycholesterol, 99.98%
MedChemExpress
  • opakowanie: 100 mg, 10mM/1mL, 5 mg, 1 mg
  • Warianty: 7
od 407,93
Zobacz produkt
7BETA-HYDROXYCHOLESTEROL, 99%
Fluorochem
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 575,86
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,7R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol (CAS 566-27-8) to związek chemiczny o wzorze sumarycznym C27H46O2 i masie molowej 402.7 g/mol. Nazwa systematyczna IUPAC: (3S,7R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol. InChIKey: OYXZMSRRJOYLLO-KGZHIOMZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H46O2
Masa molowa402.7 g/mol
Nazwa IUPAC(3S,7R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol
InChIKeyOYXZMSRRJOYLLO-KGZHIOMZSA-N
SMILESC[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C=C4[C@@]3(CC[C@@H](C4)O)C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 7beta-Hydroxycholesterol, 7-beta-OHC, 7-Hydroxycholesterol, (7beta)-, 7.beta.-Hydroxycholesterol, 7b-Hydroxycholesterol, Cholest-5-ene-3,7-diol, (3beta,7beta)-, (3b,7b)-Cholest-5-ene-3,7-diol, 7 beta-hydroxycholesterol, Cholest-5-ene-3I2,7I2-diol, cholest-5-en-3 beta,7 alpha-diol, (3beta,7beta)-isomer
Powiązane formy tego związku
(3S,7S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol C27H46O2
(3S,7R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol C27H46O2
Izomery (ten sam wzór sumaryczny)
heptacosa-10,12-diynoic acid C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-5-hydroxy-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-7,7,7-trideuterio-6-hydroxy-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2
(2R)-2,8-dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol C27H46O2
(3S,8R,9S,10R,12S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol C27H46O2
(2S,3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2,3-diol C27H46O2
(1S,2R,5S,7R,9S,11S,12S,15R,16R)-2,16-dimethyl-15-[(2R)-6-methylheptan-2-yl]-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-ol C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-[dideuterio(hydroxy)methyl]heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2